These findings suggest that disrupting signaling by IFN-γ, YAP, or the kinases connecting the IFN-γ receptor to YAP could potentially prove beneficial for some subsets of patients with or at risk of postacute sequelae of pneumonia. The gene discussed is IFNG; the disease is pneumonia.